Hematopoietic/Lymphoid Cancer Recruiting Phase 2 Trials for Dexamethasone (DB01234)

IndicationStatusPhase
DBCOND0030132 (Hematopoietic/Lymphoid Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03136146Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/LeukemiaTreatment
NCT03121534Study of Blinatumomab in Richter TransformationTreatment